B-
BiotechTV - News
Jefferies London: While its in the middle of the closely watched Attruby launch, BridgeBio has two other medicines in front of FDA and another big phase 3 readout scheduled for later next year
0:00-9:34
Founder & CEO Neil Kumar shares his take on how the Attruby launch is going, and also talks Limb-girdle muscular dystrophy type 2I/R9, achondroplasia, and hypoparathyroidism.
Publisher
BiotechTV - News
Link
podcasters.spotify.com/pod/show/biotechtv4/episodes/Jefferies-London-While-its-in-the-middle-of-the-closely-watched-Attruby-launch--BridgeBio-has-two-other-medicines-in-front-of-FDA-and-another-big-phase-3-readout-scheduled-for-later-next-year-e3sfn0q
Published
November 16, 2026
Duration
10 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
BiotechTV
B-
BiotechTV - News
@biotechtvnews
#jefferieslondon #closelywatchedattruby #readoutscheduled #lifesciences
